Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Cash & Equivalents (2016 - 2026)

Neuronetics has reported Cash & Equivalents over the past 11 years, most recently at $13.2 million for Q1 2026.

  • Quarterly Cash & Equivalents fell 34.66% to $13.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $13.2 million through Mar 2026, down 34.66% year-over-year, with the annual reading at $6.0 million for FY2025, 500.0% up from the prior year.
  • Cash & Equivalents was $13.2 million for Q1 2026 at Neuronetics, up from $6.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $80.8 million in Q1 2022 and troughed at $1.0 million in Q4 2024.
  • The 5-year median for Cash & Equivalents is $42.6 million (2024), against an average of $39.9 million.
  • Year-over-year, Cash & Equivalents tumbled 98.32% in 2024 and then surged 500.0% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $70.3 million in 2022, then fell by 15.16% to $59.7 million in 2023, then tumbled by 98.32% to $1.0 million in 2024, then surged by 500.0% to $6.0 million in 2025, then surged by 120.23% to $13.2 million in 2026.
  • Per Business Quant, the three most recent readings for STIM's Cash & Equivalents are $13.2 million (Q1 2026), $6.0 million (Q4 2025), and $28.0 million (Q3 2025).